The effect of L-dopa administration and folate deficiency on plasma homocysteine concentrations in rats

Journal of Nutritional Biochemistry

Volumn 8, Issue 11, 1997, Pages 634-640

  Daly, Deborah ^a   Miller, Joshua W ^a   Nadeau, Marie R ^a   Selhub, Jacob ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Folate; L homocysteine; S adenosylhomocysteine; S adenosylmethionine

Indexed keywords

HOMOCYSTEINE; LEVODOPA; S ADENOSYLMETHIONINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FOLIC ACID DEFICIENCY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT;

EID: 0030830299     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-2863(97)00110-1     Document Type: Article

References (38)

1. Wurtman, R.J. (1972). Effect of L-dopa on S-adenosylmethionine levels and norepinephrine metabolism in rat brain. In Advances in Biochemical Psychopharmacology, Vol. 6 (E. Costa, L.L. Iversen, and R. Paoletti, eds.), pp. 241-246, Raven Press, New York
2. Sharpless, N.S., Muenter, M.D., Tyce, G.M., and Owen, C.A. (1972). 3-Methoxy-4-hydroxyphenylalanine (3-O-methyldopa) in plasma during oral L-dopa therapy of patients with Parkinson's disease. Clin. Chim. Acta 37, 359-369
3. Da Prada, M., Keller, H.H., Pieri, L., Kettler, R., and Haefely, W.E. (1984). The pharmacology of Parkinson's disease: Basic aspects and recent advances. Experientia 40, 1165-1172
4. Kuruma, I., Bartholini, G., Tissot, R., and Pletscher, A. (1972). Comparative investigation of inhibitors of extracerebral dopa decarboxylase in man and rats. J. Pharm. Pharmacol. 24, 289-294
5. Messiha, F.S., Hsu, T.H., and Bianchine, J.R. (1972). Peripheral aromatic L-amino acids decarboxylase inhibitor in Parkinsonism. J. Clin. Invest. 51, 452-455
6. Nutt, J.G. and Fellman, J.H. (1984). Pharmacokinetics of levodopa. Clin. Neuropharmacol. 7, 35-49
7. Calne, D.B., Reid, J.L., and Vakil, S.D. (1973). Parkinsonism treated with 3-O-methyldopa. Clin. Pharmac. Ther. 14, 386-389
8. Muenter, M.D., Dinapoli, R.P., Sharpless, N.S., and Tyce, G.M. (1973). 3-O-Methyldopa, L-dopa, and trihexyphenidyl in the treatment of Parkinson's disease. Mayo Clin. Proc. 48, 173-183
9. Calne, D.B. (1993). Treatment of Parkinson's disease. N. Engl. J. Med. 329, 1021-1027
10. Chalmers, J.P., Baldessarini, R.J., and Wurtman, R.J. (1971). Effects of L-dopa on norepinephrine metabolism in the brain. Proc. Natl. Acad. Sci. USA 68, 662-666
11. Ordonez, L.A. and Wurtman, R.J. (1973). Methylation of exogenous 3,4-dihydroxyphenylalanine (L-dopa) - effects on methyl group metabolism. Biochem. Pharmacol. 22, 134-137
12. Ordonez, L.A. and Wurtman, R.J. (1974). Folic acid deficiency and methyl group metabolism in rat brain: effects of L-dopa. Arch. Biochem. Biophys. 160, 372-376
13. Baldessarini, R.J. (1975). Biological transmethylation involving S-adenosylmethionine: development of assay methods and implications for neuropsychiatry. In International Review of Neurobiology (C.C. Pfeiffer and J.R. Smythies, eds.), pp. 41-67, Academic Press, New York
14. Taylor, K.M. and Randall, P.K. (1975). Depletion of S-adenosyl-L-methionine in mouse brain by antidepressive drugs. J. Pharmacol. Exp. Ther. 194, 303-310
15. Fuller, R.W., Hemrick-Luecke, S.K., and Perry, K.W. (1982). Effects of L-dopa on epinephrine concentration in rat brain: Possible role of inhibition of norepinephrine N-methyltransferase by S-adenosylhomocysteine. J. Pharmacol. Exp. Ther. 223, 84-89
16. Fuller, R.W., Perry, K.W., and Hemrick-Luecke, S.K. (1984). Tropolone antagonism of the L-dopa-induced elevation of S-adenosylhomocysteine:S-adenosylmethionine ratio but not depletion of adrenaline in rat hypothalamus. J. Pharm. Pharmacol. 36, 419-420
17. Wagner, J., Danzin, C., Huot-Olivier, S., Claverie, N., and Palfreyman, M.G. (1984). High-performance liquid Chromatographic analysis of S-adenosylmethionine and its metabolites in rat tissues: Interrelationship with changes in biogenic catechol levels following treatment with L-dopa. J. Chromatogr. 290, 247-262
18. Taufek, H.R. and Bone, A.H. (1984). Influence of exogenous L-3,4-dihydroxyphenylalanine (L-dopa) on the methionine and S-adenosylmethionine concentrations in the brain and other tissues. Biochem. Soc. Trans. 8, 62-63
19. Matthysse, S., Lipinski, J., and Shih, V. (1971). L-dopa and S-adenosylmethionine. Clin. Chem. Acta 35, 253-254
20. Surtees, R. and Hyland, K. (1990). L-3,4-dihydroxyphenylalanine (levodopa) lowers central nervous system S-adenosylmethionine concentrations in humans. J. Neurol. Neurosurg. Psychiatry 53, 569-572
21. Walzem, R.L. and Clifford, A.J. (1988). Folate deficiency in rats fed diets containing free amino acids or intact proteins. J. Nutr. 118, 1089-1096
22. Vester, B. and Rasmussen, K. (1991). High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. Eur. J. Clin. Chem. Clin. Biochem. 29, 549-554
23. Horne, D.W. and Patterson, D. (1988). Lactobacillus casei microbiological assay of folic acid derivatives in 96-well microtiter plates. Clin. Chem. 34, 2357-2359
24. Tamura, T., Freeberg, L.E., and Cornwell, P.E. (1990). Inhibition by EDTA of growth of Lactobacillus casei in folate microbiological assay and its reversal by added manganese or iron. Clin. Chem. 36, 1993
25. Camp, V.M., Chipponi, J., and Faraj, B.A. (1983). Radioenzymatic assay for direct measurement of pyridoxal-5'-phosphate. Clin. Chem. 29, 642-644
26. Miller, J.W., Nadeau, M.R., Smith, D., and Selhub, J. (1994). Vitamin B6 deficiency vs. folate deficiency: Comparison of responses to methionine loading in rats. Am. J. Clin. Nutr. 59, 1033-1039
27. Fell, D., Benjamin, L.E., and Steele, R.D. (1985). Determination of adenosine and S-adenosyl derivatives of sulfur amino acids in rat liver by high-performance liquid chromatography. J. Chromatogr. 345, 150-156
28. Daniel, W.W. (1987). Biostatistics: A foundation for analysis in the health sciences. In Wiley Series in Probability and Mathematical Statistics, 4th ed. (V. Barnett, R.A. Bradley, and J.S. Hunter, eds.), pp. 207-266, John Wiley and Sons, New York
29. Skiba, W.E., Taylor, M.P., Wells, M.S., Mangum, J.H., and Awad, W.M.J. (1982). Human hepatic methionine biosynthesis: Purification and characterization of betaine:homocysteine S-methyltransferase. J. Biol. Chem. 257, 14944-14948
30. Finkelstein, J.D., Kyle, W.E., and Harris, B.J. (1971). Methionine metabolism in mammals: Regulation of homocysteine methyltransferases in rat tissue. Arch. Biochem. Biophys. 146, 84-92
31. Benson, R., Crowell, B., Hill, B., Doonquah, K., and Charlton, C. (1993). The effects of L-dopa on the activity of methionine adenosyltransferase: Relevance to L-dopa therapy and tolerance. Neurochem. Res. 18, 325-330
32. Schott, H.F. and Clark, W.G. (1952). Dopa decarboxylase inhibition through the interaction of coenzyme and substrate. J. Biol. Chem. 196, 449-462
33. Pfeiffer, R. and Ebadi, M. (1972). On the mechanism of the nullification of CNS effects of L-dopa by pyridoxine in Parkinsonian patients. J. Neurochem. 19, 2175-2181
34. Kott, E., Bornstein, B., and Eichhorn, F. (1971). Excretion of dopa metabolites. N. Engl. J. Med. 284, 395
35. Kurtz, D.J. and Kanfer, J.N. (1971). L-dopa: Effect on cerebral pyridoxal phosphate content and coenzyme activity. J. Neurochem. 18, 2235-2236
36. Yahr, M.D., Duvoisin, R.C., Cote, L., et al. (1972). Pyridoxine, dopa, and Parkinsonism. In Advances in Biochemical Psychopharmacology. Vol. 4 (M.S. Ebadi and E. Costa, eds.), pp. 185-194, Raven Press, New York
37. Clarke, R., Daly, L., Robinson, K., et al. (1991). Hyperhomocysteinemia: An independent risk factor for vascular disease. N. Engl. J. Med. 324, 1149-1155
38. Allain, P., Le Bouil, A., Cordillet, E., Le Quay, L., Bagheri, H., and Montastruc, J.L. (1995). Sulfate and cysteine levels in the plasma of patients with Parkinson's disease. Neurotoxicology 16, 527-529